Preussmann R, Habs M, Habs H, Schmähl D
Cancer Res. 1982 Dec;42(12):5167-71.
N-nitrosodiethanolamine, an N-nitroso compound of environmental significance, has been tested for carcinogenicity in male Sprague-Dawley rats at five different dose levels. Administration p.o. in the drinking water of 1.5, 6, 25, 100, or 400 mg N-nitrosodiethanolamine per kg per day was tolerated well. Median total doses administered were between 0.86 g/kg body weight at the highest and 100.3 g/kg body weight at the lowest dose level. Treatment-related tumors were observed in the liver and the nasal cavity. The induction of hepatocellular carcinomas was clearly dose related, low doses also inducing benign lesions. Other liver tumors were of mesenchymal and ductal origin and nasal cavity neoplasms were diagnosed as squamous-cell carcinomas and neuroepitheliomas of the olfactory epithelium. Statistical evaluation of the 1.5-mg/kg dose regimen clearly indicates that even such low doses are carcinogenic. This potent carcinogenic activity is surprising since a high percentage (60 to 90%) of an administered dose of N-nitrosodiethanolamine is excreted unchanged in the urine. Thus, we propose that an as yet unidentified metabolite may possess high carcinogenic potential.
N-亚硝基二乙醇胺是一种具有环境意义的N-亚硝基化合物,已在雄性斯普拉格-道利大鼠中进行了五种不同剂量水平的致癌性测试。经口给予饮用水中每天每千克1.5、6、25、100或400毫克N-亚硝基二乙醇胺,耐受性良好。最高剂量水平下的中位总剂量为0.86克/千克体重,最低剂量水平下为100.3克/千克体重。在肝脏和鼻腔中观察到与治疗相关的肿瘤。肝细胞癌的诱导明显与剂量相关,低剂量也诱导良性病变。其他肝脏肿瘤起源于间充质和导管,鼻腔肿瘤被诊断为鳞状细胞癌和嗅上皮神经上皮瘤。对1.5毫克/千克剂量方案的统计评估清楚地表明,即使是如此低的剂量也具有致癌性。这种强大的致癌活性令人惊讶,因为给予的N-亚硝基二乙醇胺剂量中有很大比例(60%至90%)以未改变的形式从尿液中排出。因此,我们提出一种尚未确定的代谢物可能具有很高的致癌潜力。